Skip Navigation U.S. Department of Health and Human Services www.hhs.gov/
Agency for Healthcare Research Quality www.ahrq.gov
www.ahrq.gov/

Treating Tobacco Use and Dependence: Slide Presentation (Full Set)


For the Patient Willing To Quit (Continued)

Strategy A4. Assist—Aid the patient in quitting (provide counseling and medication) (Continued)

Text Description is below the image.

Recommend the use of approved medication,

except where contraindicated or with specific populations for which there is insufficient evidence of effectiveness (i.e., pregnant women, smokeless tobacco users, light smokers and adolescents).
Recommend the use of medications. Explain how these medications increase quitting success and reduce withdrawal symptoms. The first-line medications include: bupropion SR, nicotine gum, nicotine inhaler, nicotine lozenge, nicotine nasal spray, nicotine patch and varenicline and second-line medications include: clonidine and nortriptyline. There is insufficient evidence to recommend medications for certain populations (e.g., pregnant women, adolescents, smokeless tobacco users, light smokers).

Next SlidePrevious Slide        Contents         Next Slide Next Slide


 

AHRQAdvancing Excellence in Health Care